These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8319168)

  • 1. Enhancement of cytotoxicity of doxorubicin by verapamil in the hepatic artery infusion for liver tumors in rats.
    Miyazaki M; Shimoda T; Itoh H; Kaiho T; Iinuma K; Koyama T; Nakagawa K; Andoh K; Anbiru S; Ohtawa S
    Cancer; 1993 Jul; 72(2):349-54. PubMed ID: 8319168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Enhancement of anti-tumor effect of adriamycin by verapamil in a intrahepatic arterial infusion in the rats].
    Shimoda T; Miyazaki M; Utagawa I; Koshikawa H; Ito H; Okui K
    Nihon Geka Gakkai Zasshi; 1992 May; 93(5):481-7. PubMed ID: 1614393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of verapamil and degradable starch microspheres during hepatic artery infusion of doxorubicin.
    Thom AK; Zhang SZ; Deveney C; Daly JM
    Surgery; 1990 May; 107(5):552-9. PubMed ID: 2333595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Enhancement of anti-tumor effect of adriamycin by verapamil in a hepatic arterial infusion in the rats: preliminary report].
    Shimoda T; Miyazaki M; Utagawa I; Koshikawa H; Ito H; Suzuki H; Okui K
    Nihon Geka Gakkai Zasshi; 1991 Feb; 92(2):226. PubMed ID: 2038296
    [No Abstract]   [Full Text] [Related]  

  • 5. Verapamil-reversing concentrations induce blood flow changes that could counteract in vivo the MDR-1-modulating effects.
    Ramirez LH; Munck JN; Zhao Z; Bognel C; Ricard M; Ardouin P; Rougier P; Gouyette A
    Cancer; 1994 Aug; 74(3):810-6. PubMed ID: 7913658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced therapeutic effect against liver W256 carcinosarcoma with temperature-sensitive liposomal adriamycin administered into the hepatic artery.
    Zou Y; Yamagishi M; Horikoshi I; Ueno M; Gu X; Perez-Soler R
    Cancer Res; 1993 Jul; 53(13):3046-51. PubMed ID: 8319211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Investigation of temperature sensitive liposome encapsulated adriamycin injected into hepatic artery for targeted behavior and cancer therapy].
    Zou YY; Gu XQ; Ueno M; Horikoshi I
    Yao Xue Xue Bao; 1991; 26(9):705-9. PubMed ID: 1821091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting liver tumors by administering liposomal doxorubicin into the hepatic artery.
    Zou Y; Horikoshi I; Ueno M; Gu X; Perez-Soler R
    Int J Cancer; 1992 May; 51(2):232-7. PubMed ID: 1568791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic arterial infusion of verapamil and doxorubicin with complete hepatic venous isolation and extracorporeal chemofiltration: pharmacological evaluation of reduction in systemic drug exposure and assessment of hepatic toxicity.
    Fuhrman GM; Cromeens DM; Newman RA; Cleary KR; Carrasco CH; Wright KC; Guercio S; Guercio A; Curley SA
    Surg Oncol; 1994 Feb; 3(1):17-25. PubMed ID: 8186867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Organ distribution and antitumor activity of free and liposomal doxorubicin injected into the hepatic artery.
    Zou Y; Horikoshi I; Kasagi T; Gu X; Perez-Soler R
    Cancer Chemother Pharmacol; 1993; 31(4):313-8. PubMed ID: 8422696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase I trial of intrahepatic verapamil and doxorubicin. Regional therapy to overcome multidrug resistance.
    Saltz L; Murphy B; Kemeny N; Bertino J; Tong W; Keefe D; Tzy-Jun Y; Tao Y; Kelsen D; O'Brien JP
    Cancer; 1994 Nov; 74(10):2757-64. PubMed ID: 7954234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A clinical trial of arterial infusion chemotherapy combined with calcium antagonist for liver metastases].
    Matsumoto J; Minami T; Sato T; Onodera T
    Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1553-6. PubMed ID: 1530306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional pharmacokinetics of doxorubicin following hepatic arterial and portal venous administration: evaluation with hepatic venous isolation and charcoal hemoperfusion.
    Iwasaki T; Ku Y; Kusunoki N; Tominaga M; Fukumoto T; Muramatsu S; Kuroda Y
    Cancer Res; 1998 Aug; 58(15):3339-43. PubMed ID: 9699664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentiation of doxorubicin cytotoxicity by the calcium channel blocker verapamil in Ehrlich ascites cells.
    al-Gharably NM; Osman AM; al-Shabanah OA; al-Bekairi AM; al-Harbi MM
    Chemotherapy; 1993; 39(6):410-5. PubMed ID: 8222869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hepatic arterial infusion chemotherapy combined with calcium antagonist for liver metastases].
    Matsumoto J; Minami T; Sato T; Onodera T
    Gan To Kagaku Ryoho; 1993 Aug; 20(11):1538-41. PubMed ID: 8373214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced antitumor efficacy on hepatoma-bearing rats with adriamycin-loaded nanoparticles administered into hepatic artery.
    Chen JH; Ling R; Yao Q; Wang L; Ma Z; Li Y; Wang Z; Xu H
    World J Gastroenterol; 2004 Jul; 10(13):1989-91. PubMed ID: 15222053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic evaluation of percutaneous hepatic venous isolation for administration of regional chemotherapy.
    August DA; Verma N; Vaerten MA; Shah R; Andrews JC; Brenner DE
    Surg Oncol; 1995 Aug; 4(4):205-16. PubMed ID: 8528483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of calcium antagonists on the antitumor activity and the cardiac toxicity of doxorubicin in the rat.
    Villani F; Formelli F; Monti E; Piccinini F; Favalli L; Rozza A; Lanza E; Poggi P
    Chemioterapia; 1987 Jun; 6(2 Suppl):686-7. PubMed ID: 3509522
    [No Abstract]   [Full Text] [Related]  

  • 19. Hepatic arterial infusion of mitoxantrone in the treatment of primary hepatocellular carcinoma.
    Shepherd FA; Evans WK; Blackstein ME; Fine S; Heathcote J; Langer B; Taylor B; Habal F; Kutas G; Pritchard KI
    J Clin Oncol; 1987 Apr; 5(4):635-40. PubMed ID: 3031227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased doxorubicin levels in hepatic tumors with reduced systemic drug exposure achieved with complete hepatic venous isolation and extracorporeal chemofiltration.
    Curley SA; Stone DL; Fuhrman GM; Hohn DC; Siddik ZH; Newman RA
    Cancer Chemother Pharmacol; 1993; 33(3):251-7. PubMed ID: 8269607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.